PubRank

M A Rench

Author PubWeight™ 26.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med 1988 3.14
2 Changing epidemiology of group B streptococcal colonization. Pediatrics 1999 2.09
3 Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis 2000 1.79
4 A 5-year review of recurrent group B streptococcal disease: lessons from twin infants. Clin Infect Dis 2000 1.53
5 Unusual occurrence of an epidemic of type Ib/c group B streptococcal sepsis in a neonatal intensive care unit. J Infect Dis 1987 1.51
6 Long-term sequelae of group B streptococcal meningitis in infants. J Pediatr 1985 1.49
7 Commercial latex agglutination for detection of group B streptococcal antigen in body fluids. J Pediatr 1983 1.47
8 Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis 1999 1.30
9 Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. J Infect Dis 2000 1.07
10 Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines. Infect Immun 2001 0.95
11 Class specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assay. Infect Immun 1984 0.94
12 Detection of group B streptococcal antigen in body fluids by a latex-coupled monoclonal antibody assay. J Clin Microbiol 1984 0.92
13 Role of intravenous immunoglobulin in prevention of late-onset infection in low-birth-weight neonates. The Neonatal IVIG Study Group. Rev Infect Dis 1990 0.90
14 Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection. N Engl J Med 1990 0.88
15 Failure of rifampin to eradicate group B streptococcal colonization in infants. Pediatr Infect Dis J 2001 0.85
16 Disposition of an immunoglobulin intravenous preparation in very low birth weight neonates. J Pediatr 1988 0.84
17 Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonates. J Pediatr 1994 0.81
18 Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates. Pediatr Infect Dis J 1990 0.81
19 Role of fibronectin in diagnosing bacterial infection in infancy. Am J Dis Child 1988 0.80
20 Patterns of immune response among survivors of group B streptococcal meningitis. J Infect Dis 1990 0.78
21 Single-dose pharmacokinetics of imipenem-cilastatin in neonates. Antimicrob Agents Chemother 1985 0.78
22 Fibronectin and age-limited susceptibility to type III, group B Streptococcus. J Infect Dis 1988 0.76
23 Fibronectin levels in premature infants with late-onset sepsis. J Perinatol 1993 0.75
24 Failure of urokinase to resolve Broviac catheter-related bacteremia in children. J Pediatr 1984 0.75
25 Pharmacokinetics of intravenous immunoglobulin in very low birth weight neonates. Pediatr Infect Dis J 1989 0.75
26 Neonatal sepsis caused simultaneously by two serotypes of group B Streptococcus. Pediatr Infect Dis J 1999 0.75
27 Effect of intravenously administered immune globulin on functional antibody to herpes simplex virus in low birth weight neonates. J Pediatr 1989 0.75
28 Effect of continuous heparin infusion on bactericidal activity for group B streptococci in neonatal sera. J Pediatr 1983 0.75